Cardiotonic agents. 1-Methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3 (2H)-isoquinolinones and related compounds. Synthesis and activity. 1989

T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
Pharmaceuticals Department, Mitsui Toatsu Chemicals Inc., Yokohama, Japan.

A series of 1-methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinones and related compounds were synthesized and evaluated for positive inotropic activity. Most members of this series exerted a dose-dependent increase in myocardial contractility in the dog acute heart failure model, whereas they caused only slight changes in heart rate and blood pressure. Several derivatives, especially those with cyano, acetyl, and ethyl substituents at the 4-position, were more potent than milrinone, which was used as a reference. 4-Acetyl-1-methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinone (MS-857) is one of the most potent positive inotropic agents in this series.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
October 1971, Experientia,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
May 1968, Journal of medicinal chemistry,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
November 1988, Journal of pharmacobio-dynamics,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
June 1987, Journal of medicinal chemistry,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
July 1984, Chemical & pharmaceutical bulletin,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
February 1986, Journal of medicinal chemistry,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
February 1990, Journal of medicinal chemistry,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
March 1991, Chemical & pharmaceutical bulletin,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
December 1986, Journal of medicinal chemistry,
T Kaiho, and K San-Nohe, and S Kajiya, and T Suzuki, and K Otsuka, and T Ito, and J Kamiya, and M Maruyama
January 1996, Journal of medicinal chemistry,
Copied contents to your clipboard!